Dr. Brian S. Choi , MD
Specialist • Riverside, CA
4500 Brockton Avenue, Ste. #107
Riverside, CA 92501
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
NPI assigned on May 3, 2006; this date does not establish years in practice.
-
Published CMS data list 1,866 Original Medicare Part B services in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Published rows only; this is not a quality measure.
-
Published Part B service records, 2024:
- J1100 — Injection, dexamethasone sodium phosphate, 1 mg: 706 service units.
- 99214 — Established patient outpatient office visit: 349 service units.
- 96413 — Administration of chemotherapy into vein: 132 service units.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Units differ by code; these are not visits or a measure of quality.
CPT® only copyright 2023 American Medical Association. All rights reserved. Service names are shortened from CPT Consumer Friendly Descriptors (CMS data, 2024). CPT notice
See all 16 records in the table · Guide: How to read Medicare Part B data
-
Published CMS data list 1,040 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Anastrozole — 102 prescription fills, including refills.
- Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen) — 53 prescription fills, including refills.
- Dexamethasone Sodium Phosphate — 50 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 42 records in the table · Guide: How to read Medicare Part D prescriber data
-
Close to the middle for Medicare Part B services among clinicians listed under Specialist in California (2024, 970 clinicians with data). Median for this group: 1,451. Middle half: 399 to 4,264.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part B services went from 23,731 in 2020 to 1,866 in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2020–2024.
Practice Location & Contact Primary Location
4500 Brockton Avenue
Ste. #107
Riverside, CA 92501
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
CMS Doctors and Clinicians lists 1 group name: Los Angeles Hematology-Oncology Medical Group. See the list
Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026.
Listings do not confirm current availability, employment or a shared ownership network.
Medicare Profile & Education
Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026
Northwestern University Feinberg Medical School
2003
What Public CMS Data Show
Specialist: NPPES taxonomy is a reported classification, not proof of board certification.
Medicare patients
242 people with Original Medicare in 2024
It gives a sense of how many people with Medicare this clinician treated that year.
Source: CMS, Medicare Physician & Other Practitioners – by Provider, 2024.
Medicare-allowed amount
About $110,933 in 2024
The total amount Medicare approved for these services in 2024. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.
It shows the total cost of this clinician's Original Medicare services under Medicare's fee rules.
What this does not show: Medicare-allowed amount
This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
Paid by Medicare
About $83,089 in 2024
The part of the Medicare-allowed amount that Medicare itself paid in 2024, after patients' deductibles and coinsurance.
The gap between the allowed amount and this number is roughly what patients and their other insurance paid.
What this does not show: Paid by Medicare
This is not the clinician's income and not a measure of quality.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
30-day fills
1,360 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$3,450,307 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $6,502.10 across 283 records.
By nature of payment
- Food and Beverage: $6,502.10 across 283 records.
Reporting-company totals (3 largest of 62)
- Janssen Pharmaceuticals, Inc: $485.17 across 17 records.
- Merck Sharp & Dohme LLC: $467.22 across 15 records.
- Novartis Pharmaceuticals Corporation: $464.06 across 29 records.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
Years since graduation
23 years (graduated 2003)
CMS Doctors and Clinicians data list 2003 as the year this clinician finished professional school.
It tells you roughly how long ago the clinician finished school.
What this does not show: Years since graduation
It is not the number of years in practice, and more years does not mean better care.
Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026.
NPI first issued
2006
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Accepts Medicare assignment
CMS data list this clinician as accepting Medicare assignment. This means agreeing to take the Medicare-approved amount as full payment for covered services.
With Original Medicare, you usually pay only your deductible and coinsurance, and the office sends the claim to Medicare for you.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians, CMS release of October 2, 2026; Medicare.gov, “Does your provider accept Medicare as full payment?”
Telehealth (some services)
Recent Medicare claims show this clinician provided some services by telehealth, such as a video or phone visit.
You may be able to have some visits without going to the office. Ask which visits can be done by telehealth.
What this does not show: Telehealth (some services)
It does not mean all services are offered by telehealth, or that telehealth is covered by your plan.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians, CMS release of October 2, 2026.
Enrolled in Medicare (PECOS)
Dr. Choi has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Dr. Choi as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Riverside and California
Billing and prescribing volume is not a quality rating.
Medicare Part B services
Close to the middle for clinicians listed under Specialist in California (2024, 970 clinicians with data). Median for this group: 1,451. Middle half: 399 to 4,264.
Too few clinicians listed under Specialist in Riverside have Medicare Part B data for 2024 to compare.
Medicare-allowed amount
Close to the middle for clinicians listed under Specialist in California (2024, 970 clinicians with data). Median for this group: $122,735. Middle half: $39,934 to $306,970.
Too few clinicians listed under Specialist in Riverside have Medicare Part B data for 2024 to compare.
Paid by Medicare
Close to the middle for clinicians listed under Specialist in California (2024, 970 clinicians with data). Median for this group: $93,704. Middle half: $29,348 to $234,121.
Too few clinicians listed under Specialist in Riverside have Medicare Part B data for 2024 to compare.
Medicare Part D prescriptions
More Part D prescriptions than 60% of clinicians listed under Specialist in California (2024, 1,050 clinicians with data). Median for this group: 502. Middle half: 100 to 1,752.
Too few clinicians listed under Specialist in Riverside have Medicare Part D data for 2024 to compare.
Part D drug cost
A higher Part D drug cost than 95% of clinicians listed under Specialist in California (2024, 1,050 clinicians with data). Median for this group: $36,643. Middle half: $2,246 to $302,438.
Too few clinicians listed under Specialist in Riverside have Medicare Part D data for 2024 to compare.
54 active clinicians are listed under Specialist with a practice address in Riverside, CA (5,763 in California).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in Riverside
5.6% of these 54 clinicians have the CMS telehealth indicator.
14.8% of these 54 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part B services
Medicare Part B services decreased 92% from 23,731 in 2020 to 1,866 in 2024.
- 2020: 23,731
- 2021: 623
- 2022: 568
- 2023: 2,689
- 2024: 1,866
-
Medicare-allowed amount
Medicare-allowed amount decreased 28% from $153,198 in 2020 to $110,933 in 2024.
- 2020: $153,198
- 2021: $79,788
- 2022: $74,554
- 2023: $109,887
- 2024: $110,933
-
Paid by Medicare
Paid by Medicare decreased 28% from $115,922 in 2020 to $83,089 in 2024.
- 2020: $115,922
- 2021: $59,198
- 2022: $54,249
- 2023: $82,523
- 2024: $83,089
-
Medicare Part D prescriptions
Medicare Part D prescriptions increased 125% from 463 in 2020 to 1,040 in 2024.
- 2020: 463
- 2021: 541
- 2022: 486
- 2023: 986
- 2024: 1,040
-
30-day fills
30-day fills increased 145% from 555 in 2020 to 1,360 in 2024.
- 2020: 555
- 2021: 796
- 2022: 769
- 2023: 1,268
- 2024: 1,360
-
Part D drug cost
Part D drug cost increased 106% from $1,677,569 in 2020 to $3,450,307 in 2024.
- 2020: $1,677,569
- 2021: $1,809,803
- 2022: $1,588,431
- 2023: $3,506,595
- 2024: $3,450,307
-
Industry payments (Open Payments)
Industry payments (Open Payments) increased 50% from $4,343.02 in 2021 to $6,502.10 in 2025.
- 2021: $4,343.02
- 2022: $5,081.12
- 2023: $4,620.32
- 2024: $6,585.24
- 2025: $6,502.10
Sources: CMS Medicare Physician & Other Practitioners (2024), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS release of October 2, 2026, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 – December 31, 2025): 283 records totaling $6,502.10.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| ADC THERAPEUTICS AMERICA, INC. |
Food and Beverage
Cash or cash equivalent
|
ZYNLONTA | General | $104.50 |
| Stemline Therapeutics Inc. |
Food and Beverage
In-kind items and services
|
Orserdu | General | $45.99 |
| Aveo Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
FOTIVDA | General | $40.03 |
| Deciphera Pharmaceuticals Inc. |
Food and Beverage
In-kind items and services
|
QINLOCK | General | $37.89 |
| SOBI, INC |
Food and Beverage
In-kind items and services
|
Doptelet | General | $35.57 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
ELAHERE | General | $34.88 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
ULTOMIRIS | General | $34.79 |
| Gilead Sciences, Inc. |
Food and Beverage
In-kind items and services
|
Trodelvy | General | $34.72 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
IMFINZI | General | $34.69 |
| Merck Sharp & Dohme LLC |
Food and Beverage
In-kind items and services
|
KEYTRUDA | General | $34.68 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
ELAHERE | General | $34.55 |
| Merck Sharp & Dohme LLC |
Food and Beverage
In-kind items and services
|
KEYTRUDA | General | $34.28 |
| Janssen Pharmaceuticals, Inc |
Food and Beverage
In-kind items and services
|
TALVEY | General | $34.06 |
| PharmaEssentia USA Corporation |
Food and Beverage
In-kind items and services
|
BESREMI | General | $33.98 |
| Merck Sharp & Dohme LLC |
Food and Beverage
In-kind items and services
|
KEYTRUDA | General | $33.76 |
| Novartis Pharmaceuticals Corporation |
Food and Beverage
In-kind items and services
|
LUTATHERA | General | $33.75 |
| PharmaEssentia USA Corporation |
Food and Beverage
In-kind items and services
|
BESREMI | General | $33.69 |
| BeOne Medicines USA, Inc. |
Food and Beverage
In-kind items and services
|
TEVIMBRA | General | $33.63 |
| Syndax Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
— | General | $33.59 |
| Merck Sharp & Dohme LLC |
Food and Beverage
In-kind items and services
|
KEYTRUDA | General | $33.57 |
| Merck Sharp & Dohme LLC |
Food and Beverage
In-kind items and services
|
KEYTRUDA | General | $33.55 |
| Bayer Healthcare Pharmaceuticals Inc. |
Food and Beverage
In-kind items and services
|
Nubeqa | General | $33.07 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
ELAHERE | General | $33.06 |
| BeOne Medicines USA, Inc. |
Food and Beverage
In-kind items and services
|
BRUKINSA | General | $32.98 |
| Merck Sharp & Dohme LLC |
Food and Beverage
In-kind items and services
|
KEYTRUDA | General | $32.94 |
(top 25 shown)
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Performed Procedures & Service Volume
CPT® is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2016–2023 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners – by Provider and Service data, 2017–2024; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
| HCPCS Code | Services | Patients | Submitted Charge | Medicare Allowed |
|---|---|---|---|---|
|
J1100
Injection, dexamethasone sodium phosphate, 1 mg
|
706 | 15 | $1.44 | $0.11 |
|
99214
Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
|
349 | 145 | $325.56 | $131.66 |
|
96413
Administration of chemotherapy into vein, 1 hour or less
|
132 | 21 | $367.60 | $138.36 |
|
96127
Assessment of emotional or behavioral problems
|
119 | 108 | $15.25 | $4.95 |
|
96367
Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less
|
94 | 19 | $87.26 | $30.03 |
|
96415
Administration of chemotherapy into vein, each additional hour
|
77 | 14 | $87.28 | $29.22 |
|
99215
Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
|
66 | 34 | $419.04 | $184.83 |
|
99233
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes
|
65 | 37 | $295.13 | $118.20 |
|
96372
Injection of drug or substance under skin or into muscle
|
52 | 13 | $58.39 | $14.99 |
|
96417
Administration of additional new drug or substance into vein, 1 hour or less
|
48 | 11 | $176.45 | $68.22 |
|
99223
Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes
|
44 | 44 | $421.01 | $172.84 |
|
36415
Insertion of needle into vein for collection of blood sample
|
33 | 14 | $15.00 | $8.65 |
|
85025
Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count
|
25 | 11 | $25.00 | $7.61 |
|
99205
New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more
|
21 | 21 | $536.11 | $225.42 |
|
99204
New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
|
18 | 18 | $431.54 | $171.10 |
|
96365
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less
|
17 | 12 | $172.33 | $67.68 |
Source: CMS Part B by Provider and Service, 2024; services under 11 beneficiaries omitted by CMS. Privacy limits
Submitted charges are billed amounts, not a price quote for your visit.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Anastrozole | Anastrozole | 102 | 8,165 | $3,033.13 | 40 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 53 | 1,059 | $884.20 | 17 |
| Dexamethasone Sodium Phosphate | Dexamethasone Sodium Phosphate | 50 | 1,253 | $120.54 | 17 |
| Palonosetron Hcl | Palonosetron Hcl | 39 | 826 | $1,531.70 | 14 |
| Famotidine | Famotidine | 38 | 1,637 | $161.58 | 18 |
| Fosaprepitant Dimeglumine | Fosaprepitant Dimeglumine | 38 | 803 | $3,213.34 | 13 |
| Brukinsa | Zanubrutinib | 37 | 1,110 | $403,019.94 | — |
| Prednisone | Prednisone | 34 | 840 | $95.84 | 15 |
| Ruxience | Rituximab-Pvvr | 34 | 714 | $129,114.75 | — |
| Dexamethasone | Dexamethasone | 32 | 1,320 | $820.98 | 23 |
| Orgovyx | Relugolix | 31 | 926 | $80,389.46 | — |
| Diphenhydramine Hcl | Diphenhydramine Hcl | 30 | 770 | $59.06 | 11 |
| Ondansetron Hcl | Ondansetron Hcl/Pf | 30 | 791 | $87.11 | 12 |
| Ibrance | Palbociclib | 29 | 812 | $439,963.90 | — |
| Carboplatin | Carboplatin | 26 | 602 | $1,026.76 | 11 |
| Pomalyst | Pomalidomide | 25 | 700 | $562,124.89 | — |
| Sodium Chloride | 0.9 % Sodium Chloride | 24 | 602 | $53.93 | — |
| Imatinib Mesylate | Imatinib Mesylate | 23 | 690 | $8,592.51 | — |
| Letrozole | Letrozole | 22 | 1,450 | $510.84 | 11 |
| Ondansetron Odt | Ondansetron | 21 | 355 | $293.07 | 18 |
| Famotidine | Famotidine/Pf | 21 | 476 | $22.46 | — |
| Paclitaxel | Paclitaxel | 20 | 511 | $2,238.00 | — |
| Valacyclovir | Valacyclovir Hcl | 19 | 1,410 | $1,602.82 | — |
| Xtandi | Enzalutamide | 18 | 540 | $219,073.79 | — |
| Cyclophosphamide | Cyclophosphamide | 18 | 378 | $9,720.84 | — |
(top 25 shown)
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
Self-certified to NPPES: 2020-01-23NUCC Taxonomy Code: 174400000X
An individual educated and trained in an applied knowledge discipline used in the performance of work at a level requiring knowledge and skills beyond or apart from that provided by a general education or liberal arts degree.
NUCC Taxonomy Code: 174400000X
An individual educated and trained in an applied knowledge discipline used in the performance of work at a level requiring knowledge and skills beyond or apart from that provided by a general education or liberal arts degree.
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - HEMATOLOGY/ONCOLOGY
I20090630000355
CA
6709937832
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Medicare Group Practice Enrollments
Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026
Los Angeles Hematology-Oncology Medical Group
11180 Warner Ave, Fountain Valley, CA 927087516
Phone: 7146980300
Los Angeles Hematology-Oncology Medical Group
1211 W La Palma Ave, Anaheim, CA 928012810
Phone: 7149991465
Los Angeles Hematology-Oncology Medical Group
1245 Wilshire Blvd, Los Angeles, CA 900174803
Phone: 2139771214
Los Angeles Hematology-Oncology Medical Group
260 E Ontario Ave, Corona, CA 928793508
Phone: 9513712411
Los Angeles Hematology-Oncology Medical Group
4500 Brockton Ave, Riverside, CA 925014006
Phone: 9512762760
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Internal Medicine - Hematology & Oncology
Doctor of Medicine (M.D.)
Nurse Practitioner
NURSEPRACTITIONER
Nurse Practitioner
Family Nurse Practitioner
Career & Practice History Timeline
Changes recorded in monthly NPPES data files: addresses, names, credentials, specialties and NPI status
Registered at 4500 BROCKTON AVE, STE 107, RIVERSIDE, CA 925014006 (Tel: 7146980300)
NPI status registered as active in NPPES database
Registered at 4500 BROCKTON AVENUE, STE. #107, RIVERSIDE, CA 92501 (Tel: 9512762760)
Registered at 18111 BROOKHURST STREET, STE. #6100, FOUNTAIN VALLEY, CA 927087516 (Tel: 7146980300)
Recorded as BRIAN CHOI, M.D.
Specialist (license number reported to NPPES: CA A104454)
First registered as active Individual Practitioner in NPPES Database.
NPI Administrative Meta
Other Specialists in Riverside
- Dr. Chidozie Mbagwu, MD, PhD
- Dr. Mojdeh Najle-Rahim, MD
- Dr. Elissa Gropen, MD
- Katherine Lesko
- Dr. Ben Childers, MD
- Dr. Mohammed Khan, MD
Mailing Address
4500 Brockton Ave, Ste 107
Riverside, CA 925014006
Phone: 7146980300